Cytonome/ST, a producer and developer specialising in sorting systems and advanced cell cytometry has combined its parallel detection technology and the cross-contamination free sampling method to identify rare target particles.
With this method the company was able to identify 60 target particles that were fluorescent from a sample that contained around 640 million non-fluorescent particles within an hour.
The parallel detection technology from Cytonome/ST uses a microfluidic chip, which divides the path of the fluid into two parallel channel flows in order to increase the output as compared to regular flow cytometers. According to John Sharpe who is the CEO of Cytonome/ST, its parallel detection technology is useful in applications where it is necessary to identify rare target particles and in communities that use diagnosis, clinical flow cytometry and research.
Cytonome/ ST is based in Massachusetts, USA has also developed a high speed cell sorting system called the Gigasort, which has the ability to sort cells under closed and sterile environments thus ensuring safety to the operators and allows the sample to stay isolated. The company has developed this technology specifically for environments that use the cGMP cell production method. The Gigasort sorting system will particularly be useful for research and treatment of cancer, autoimmune diseases and for creating regenerative medicines.
Source: http://www.CytonomeST.com